An official website of the United States government
Home
Name
VMPT
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for VMPT
Name
Alternate Names
K-17
Kevadon
Synovir
Thalomid
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Antiangiogenic agent for most indications
NSC Number
66847
Primary Site
Histology
None
Remarks
FDA approved for multiple myeloma 2006; Phase II brain, kidney, liver, lung, leukemia, HD, NHL, melanoma Phase III prostate Tumor Necrosis Factor inhibitor; angiogenesis inhibitor; immunomodulator. Celgene, NCI.
Coding
This drug should be coded
Name
Alternate Names
Alanine mustard
Alkeran
CB-3025
DL Sarcolysine
DL-O-Sarcolysin
L-Phenylalanine Mustard
L-Sarcolysin
Melfalan
Phenylalanine Mustard
Sarcolysine
Sarkoklorin
Sarkolizin
WR-19813
Abbreviations
L-PAM
MPL
PAM
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
8806
008806
57199
Primary Site
Histology
None
Remarks
Alkylating antineoplastic agent. FDA approved uses on multiple myeloma and epithelial non-resectable ovarian carcinoma.
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Coding
This drug should be coded
Name
Alternate Names
Alti-Prednisone
Alto-Pred
Ancortone
Apo-Prednisone
Colisone
Cortan
Dacortin
Delta-Dome#
Deltasone
Deltra
Fernisone Buffered
Keysone
Liquid Pred
Meticorten
Novo-Prednisone
Orasone
Panasol
Paracort#
Prednicen M
SK-Prednisone
Sterapred DS
Ultracorten
Winpred
Abbreviations
PDN
PRD
PRED
Category
Hormones and hormonal mechanisms
Subcategory
Glucocorticoid
NSC Number
10023
010023
Primary Site
Histology
None
Remarks
Code Prednisone when it is part of a drug regimen.
Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.
Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.
Coding
Please see remarks for additional information
Name
Alternate Names
LDP-341
MLN-341
PS-341
Velcade
Abbreviations
None
Category
Chemotherapy
Subcategory
Proteasome Inhibitor
NSC Number
681239
Primary Site
Histology
None
Remarks
November 14, 2014 update: FDA approved to treat multiple myeloma and Mantle cell lymphoma. In clinical trials for breast, colorectal, and lung cancer.
Coding
This drug should be coded
